The Fourth Expert Meeting of the Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Consortium took place in Barcelona on October 19 and 20, 2012. This meeting focused on the translation of preclinical data into early clinical settings. This position paper highlights the main topics explored on the safety and efficacy of mesenchymal stem cells as a therapeutic agent in solid organ transplantation and emphasizes the issues (proper timing, concomitant immunossupression, source and immunogenicity of mesenchymal stem cells, and oncogenicity) that have been addressed and will be followed up by the MiSOT Consortium in future studies.
Mesenchymal stem cells in solid organ transplantation (MiSOT) fourth meeting: Lessons learned from first clinical trials / M. Franquesa, M.J. Hoogduijn, M.E. Reinders, E. Eggenhofer, A.U. Engela, F.K. Mensah, J. Torras, A. Pileggi, C. Van Kooten, B. Mahon, O. Detry, F.C. Popp, V. Benseler, F. Casiraghi, C. Johnson, J. Ancans, B. Fillenberg, O. Delarosa, J.M. Aran, M. Roemeling-Vanrhijn, J. Pinxteren, N. Perico, E. Gotti, B. Christ, J. Reading, M. Introna, R. Deans, M. Shagidulin, R. Farré, A. Rambaldi, A. Sanchez-Fueyo, N. Obermajer, A. Pulin, F.J.M.F. Dor, I. Portero-Sanchez, C.C. Baan, T.J. Rabelink, G. Remuzzi, M.G.H. Betjes, M.H. Dahlke, J.M. Grinyó. - In: TRANSPLANTATION. - ISSN 0041-1337. - 96:3(2013 Aug), pp. 234-238.
Mesenchymal stem cells in solid organ transplantation (MiSOT) fourth meeting: Lessons learned from first clinical trials
A. Rambaldi;G. Remuzzi;
2013
Abstract
The Fourth Expert Meeting of the Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Consortium took place in Barcelona on October 19 and 20, 2012. This meeting focused on the translation of preclinical data into early clinical settings. This position paper highlights the main topics explored on the safety and efficacy of mesenchymal stem cells as a therapeutic agent in solid organ transplantation and emphasizes the issues (proper timing, concomitant immunossupression, source and immunogenicity of mesenchymal stem cells, and oncogenicity) that have been addressed and will be followed up by the MiSOT Consortium in future studies.
| File | Dimensione | Formato | |
|---|---|---|---|
|
00007890-201308150-00004.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
159.11 kB
Formato
Adobe PDF
|
159.11 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
